US Penny Stocks Under $90M Market Cap To Watch

In This Article:

As the U.S. stock market takes a breather after a significant post-election rally, investors are assessing their portfolios amid heightened optimism and fluctuating indices. In this context, penny stocks—often representing smaller or newer companies—remain an intriguing investment area despite their vintage name. These stocks can offer growth opportunities at lower price points when backed by solid financials, presenting potential for impressive returns without the typical risks associated with this segment of the market.

Top 10 Penny Stocks In The United States

Name

Share Price

Market Cap

Financial Health Rating

BAB (OTCPK:BABB)

$0.78

$5.56M

★★★★★★

RLX Technology (NYSE:RLX)

$1.60

$2.07B

★★★★★★

QuantaSing Group (NasdaqGM:QSG)

$3.08

$170.72M

★★★★★★

AsiaFIN Holdings (OTCPK:ASFH)

$0.97

$79.11M

★★★★★★

Flexible Solutions International (NYSEAM:FSI)

$4.37

$51.05M

★★★★★★

Data Storage (NasdaqCM:DTST)

$4.84

$33.86M

★★★★★★

PHX Minerals (NYSE:PHX)

$3.35

$128.93M

★★★★★☆

So-Young International (NasdaqGM:SY)

$1.25

$88.26M

★★★★☆☆

Better Choice (NYSEAM:BTTR)

$2.15

$3.78M

★★★★★★

ZTEST Electronics (OTCPK:ZTST.F)

$0.255

$9.81M

★★★★★★

Click here to see the full list of 738 stocks from our US Penny Stocks screener.

Underneath we present a selection of stocks filtered out by our screen.

Aadi Bioscience

Simply Wall St Financial Health Rating: ★★★★★★

Overview: Aadi Bioscience, Inc. is a biopharmaceutical company focused on developing and commercializing precision therapies for genetically defined cancers with alterations in mTOR pathway genes, with a market cap of $52.38 million.

Operations: Aadi Bioscience, Inc. has not reported any revenue segments.

Market Cap: $52.38M

Aadi Bioscience, Inc., with a market cap of US$52.38 million, is navigating significant strategic shifts amid its current unprofitable status. The company reported third-quarter revenue of US$7.21 million, an increase from the previous year, yet it continues to incur net losses. Recent operational changes include halting a key clinical trial and reducing its workforce by 32% to extend its cash runway into at least the second half of 2026. Despite these challenges, Aadi remains debt-free with short-term assets exceeding both short and long-term liabilities, providing some financial stability in this volatile sector.

NasdaqCM:AADI Debt to Equity History and Analysis as at Nov 2024
NasdaqCM:AADI Debt to Equity History and Analysis as at Nov 2024

PodcastOne

Simply Wall St Financial Health Rating: ★★★★★★

Overview: PodcastOne, Inc. operates as a podcast platform and publisher with a market cap of $34.82 million.